chronic coronary heart disease. Unstable angina Angina: crescendo de novo effort worsening effort Intermediate coronary syndrome Preinfarction syndrome , Acute myocardial infarction Incl.: myocardial infarction specified as acute or with a sta
Conditions
Interventions
Intervention 1: Eight weekly sessions of group positive psychotherapy based on optimism for 2 hours a week (psychology intervention). Intervention 2: Eight weekly sessions of group education about the
Eight weekly sessions of group positive psychotherapy based on optimism for 2 hours a week (psychology intervention)
Eight weekly sessions of group education about the disease without reference to psychological topics
Sponsors
Vice chancellor for research, Payam Noor University
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 60 Years
Inclusion criteria
Inclusion criteria: inclusion criteria are as the following; patients with Coronary Heart diseases (stable angina, unstable angina and myocardial infarction); a minimum 70 percent blocked in one of the coronary arteries based on angiography; passage of at least six months from the acute or inflammatory phase of the disease; age between 35 to 60 years; above elementary education level; Patient consent to participation in research. Exclusion criteria are: history of Inflammatory and autoimmune diseases, current serious psychiatric disorders; taking immunologic or psychiatric drugs; unwilling to participate or continue the research.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Optimism. Timepoint: preintervention, postintervention and two month after intervention. Method of measurement: Life orientation questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Happiness. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Oxford Happiness questionnaire.;Depression. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Hospital Anxiety and depression Scale.;Anxiety. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Hospital Anxiety and depression Scale.;Positive affect. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Positive and negative affect.;Hope. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Life Hope Questionnaire.;Satisfaction With Life. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Dinner Satisfaction With Life Scale.;Physical activities. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Six- Minute Walking Test.;Drug Adherence. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Drug Adherence Questionnaire.;Food regime adherence. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: Food Frequency Questionnaire.;Inflammation marker, hs- CRP. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: blood test.;Inflammation marker, Fibrinogen. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: blood test.;Inflammation marker ,interleukin-6. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: blood test.;Inflammation marker, Irizin. Timepoint: preintervention, postintervention and one month after intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Mohammadi
Isfahan University of Medical sciences
Outcome results
None listed